+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics (IVD) Analyzers: Global Market

  • PDF Icon

    Report

  • 132 Pages
  • April 2022
  • Region: Global
  • BCC Research
  • ID: 5575412
The current report provides detailed exposure to the in vitro diagnostic analyzer market. This report highlights the current and future market potential of in vitro diagnostic analyzers along with a detailed analysis of the drivers, challenges and opportunities in the market. The report also covers market projections to 2026 and market rank for key market players. It covers the competitive environment, patent analysis and regulatory scenario. The report details the market shares of IVD analyzers based on test type, automation, design, application and end-user. The market is segmented into immunoassay analyzers, clinical chemistry, hematology and hemostasis analyzers, molecular diagnostic analyzers, POC analyzers and others based on test type. By automation, analyzers are categorized into semi-automated and fully automated analyzers. Applications are infectious disease, diabetes, oncology, cardiology, nephrology and others. The market is segmented into hospitals, diagnostic centers, pharmaceutical companies, contract research organizations and academic research institutes, by end users. This report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report also describes the impact of the COVID-19 pandemic on this market.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World regions. The North American region includes countries such as the U.S., Canada and Mexico, Europe includes Germany, the U.K., Italy and the Rest of Europe region, Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific region. For market estimates, data has been provided for 2019 as the historic year, 2020 as the base year and a forecast for 2026. The report does not cover the applications in other industries such as the veterinary and food industries.



Report Includes

  • 27 data tables and 22 additional tables
  • An overview of the global market for In Vitro Diagnostics (IVD) analyzers
  • Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Characterization and quantification of market potential for In Vitro Diagnostics (IVD) analyzers by region, type, automation, application, therapeutic area and end user
  • Information on new detection technologies and description of technological advances in fluidics for POC testing
  • Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and market forecast
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Quidel Corp, Roche and Siemens Healthineers AG
Frequently Asked Questions about the Global In Vitro Diagnostics Market

What is the estimated value of the Global In Vitro Diagnostics Market?

The Global In Vitro Diagnostics Market was estimated to be valued at $11.6 Billion in 2021.

What is the growth rate of the Global In Vitro Diagnostics Market?

The growth rate of the Global In Vitro Diagnostics Market is 4.6%, with an estimated value of $14.5 Billion by 2026.

What is the forecasted size of the Global In Vitro Diagnostics Market?

The Global In Vitro Diagnostics Market is estimated to be worth $14.5 Billion by 2026.

Who are the key companies in the Global In Vitro Diagnostics Market?

Key companies in the Global In Vitro Diagnostics Market include Abbott Laboratories, Becton, Dickinson and Company, Bio, Rad Laboratories Inc., Biomerieux Sa, Danaher, Ekf Diagnostics Holdings plc, Mindray Medical International Ltd. and Roche Diagnostics Corp..

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports

Chapter 2 Summary and Highlights
  • Highlights of the Market for Ivd Analyzers

Chapter 3 Ivd Analyzers Market: Background and Technology
  • In Vitro Diagnostic (Ivd) Analyzer Overview

Chapter 4 Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Market Challenges
  • Market Opportunities
  • Ivds for Neglected Infectious Diseases
  • New Detection Technologies
  • Technology Advancements
  • Multiple Detection in a Single Instrument

Chapter 5 Market Breakdown by Analyzer Type
  • Global Market for in Vitro Diagnostic (Ivd) Analyzers
  • Market Analysis
  • Immunoassay Analyzers
  • Market Size and Forecast
  • Clinical Chemistry Analyzers
  • Market Size and Forecast
  • Hematology and Hemostasis Analyzers
  • Market Size and Forecast
  • Molecular Diagnostic Analyzers
  • Market Size and Forecast
  • Point-Of-Care (Poc) Analyzers
  • Market Size and Forecast
  • Other Analyzers
  • Market Size and Forecast

Chapter 6 Market Breakdown by Automation
  • Global Market for Ivd Analyzers by Automation
  • Semi-Automated Analyzers
  • Fully Automated Analyzers

Chapter 7 Market Breakdown by Therapeutic Area
  • Global Market for Ivd Analyzers by Therapeutic Area
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Other Therapeutic Areas

Chapter 8 Market Breakdown by End-user
  • Global Market for Ivd Analyzers by End-user
  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Research Institutions
  • Other End-users

Chapter 9 Market Breakdown by Region
  • Global Market for Ivd Analyzers, by Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe
  • Asia-Pacific
  • China
  • Australia
  • Japan
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 10 Regulatory Scenario
  • Ivd Regulations in North America
  • United States
  • Canada
  • Mexico
  • Ivd Regulations in Europe
  • Ivd Regulations in Asia-Pacific
  • Ivd Regulations in Row (Latin America, Africa and Middle East)

Chapter 11 Impact of the Covid-19 Pandemic
  • Impact of Covid-19 on the Ivd Analyzer Market
  • Covid-19 Impact on Device Manufacturers

Chapter 12 Competitive Landscape
  • Market Share Analysis
  • Recent Developments of Key Market Players

Chapter 13 Company Profiles
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Ekf Diagnostics Holdings plc
  • Mindray Medical International Ltd.
  • Quidel Corp.
  • Roche Diagnostics Corp.
  • Siemens Healthineers AG
  • Sysmex
  • Thermo Fisher Scientific Inc.

List of Tables
Summary Table: Global Market for IVD Analyzers, by Analyzer Type, Through 2026
Table 1: Global Market for IVD Analyzers, by Analyzer Type, Through 2026
Table 2: Global Market for Immunoassay Analyzers, by Region, Through 2026
Table 3: Key Analytes Tested in the Clinical Chemistry Laboratory
Table 4: Global Market for Clinical Chemistry Analyzers, by Region, Through 2026
Table 5: Global Market for Hematology and Hemostasis Analyzers, by Region, Through 2026
Table 6: Global Market for Molecular Diagnostic Analyzers, by Region, Through 2026
Table 7: Global Market for POC Analyzers, by Region, Through 2026
Table 8: Global Market for Other Analyzers, by Region, Through 2026
Table 9: Global Market for IVD Analyzers, by Automation, Through 2026
Table 10: Global Market for Semi-Automated Analyzers, by Region, Through 2026
Table 11: Global Market for Fully Automated Analyzers, by Region, Through 2026
Table 12: Global Market for IVD Analyzers, by Therapeutic Area, Through 2026
Table 13: Global Market for IVD Analyzers for Infectious Diseases, by Region, Through 2026
Table 14: Global Market for IVD Analyzers for Diabetes, by Region, Through 2026
Table 15: Global Market for IVD Analyzers for Oncology, by Region, Through 2026
Table 16: Global Market for IVD Analyzers for Cardiology, by Region, Through 2026
Table 17: Global Market for IVD Analyzers for Nephrology, by Region, Through 2026
Table 18: Global Market for IVD Analyzers for Other Therapeutic Areas, by Region, Through 2026
Table 19: Global Market for IVD Analyzers, by End User, Through 2026
Table 20: Global Market for IVD Analyzers Used in the Diagnostic Laboratories, by Region, Through 2026
Table 21: Global Market for IVD Analyzers Used in the Hospitals and Clinics, by Region, Through 2026
Table 22: Global Market for IVD Analyzers Used in the Research Institutions, by Region, Through 2026
Table 23: Global Market for IVD Analyzers Used in the Others, by Region, Through 2026
Table 24: Global Market for IVD Analyzers, by Region, Through 2026
Table 25: North American Market for IVD Analyzers, by Country, Through 2026
Table 26: European Market for IVD Analyzers, by Country, Through 2026
Table 27: Asia-Pacific Market for IVD Analyzers, by Country, Through 2026
Table 28: Collaborations and Acquisitions Portfolio, 2020 and 2021
Table 29: Abbott Laboratories: Product Portfolio
Table 30: Becton, Dickinson and Company: Product Portfolio
Table 31: Becton, Dickinson and Company: Key Developments
Table 32: BioMerieux SA: Product Portfolio
Table 33: Bio-Rad Laboratories Inc.: Products Portfolio
Table 34: Bio-Rad Laboratories Inc.: Recent Developments
Table 35: Danaher Corp.: Product Portfolio
Table 36: EKF Diagnostics Holdings PLC: Product Portfolio
Table 37: EKF Diagnostics Holdings PLC: Key Developments
Table 38: Mindray Medical International Ltd.: Product Portfolio
Table 39: Quidel Corp.: Product Portfolio
Table 40: Quidel Corp.: Key Developments
Table 41: Roche Diagnostics Corp.: Product Portfolio
Table 42: Roche Diagnostics Corp.: Key Developments
Table 43: Siemens Healthineers: Product Portfolio
Table 44: Siemens Healthineers.: Key Developments
Table 45: Sysmex: Product Portfolio
Table 46: Sysmex: Key Developments
Table 47: Thermo Fisher Scientific Inc.: Product Portfolio
Table 48: Thermo Fisher Scientific Inc.: Key Developments
List of Figures
Summary Figure: Global Market for IVD Analyzers, by Analyzer Type, 2019-2026
Figure 1: Role of In Vitro Diagnostics (IVDs) in Health Care
Figure 2: Global Market Shares of IVD Analyzers, by Analyzer Type, 2020
Figure 3: Global Market for Immunoassay Analyzers, by Region, 2019-2026
Figure 4: Global Market Shares of Immunoassay Analyzers, by Region, 2020
Figure 5: Global Market for Clinical Chemistry Analyzers, by Region, 2019-2026
Figure 6: Global Market Shares of Clinical Chemistry Analyzers, by Region, 2020
Figure 7: Global Market for Hematology and Hemostasis Analyzers, by Region, 2019-2026
Figure 8: Global Market Shares of Hematology and Hemostasis Analyzers, by Region, 2020
Figure 9: Global Market for Molecular Diagnostic Analyzers, by Region, 2019-2026
Figure 10: Global Market Shares of Molecular Diagnostic Analyzers, by Region, 2020
Figure 11: Global Market for POC Analyzers, by Region, 2019-2026
Figure 12: Global Market Shares of POC Analyzers, by Region, 2020
Figure 13: Global Market for Other Analyzers, by Region, 2019-2026
Figure 14: Global Market Shares of Other Analyzers, by Region, 2020
Figure 15: Global Market Shares of IVD Analyzers, by Automation, 2020
Figure 16: Global Market for Semi-Automated Analyzers, 2019-2026
Figure 17: Global Market for Fully Automated Analyzers, 2019-2026
Figure 18: Global Market Shares of IVD Analyzers, by Therapeutic Area, 2020
Figure 19: Global Market for IVD Analyzers for Infectious Diseases, 2019-2026
Figure 20: Global Market for IVD Analyzers for Diabetes, 2019-2026
Figure 21: Global Market for IVD Analyzers for Oncology, 2019-2026
Figure 22: Global Market for IVD Analyzers for Cardiology, 2019-2026
Figure 23: Global Market for IVD Analyzers for Nephrology, 2019-2026
Figure 24: Global Market for IVD Analyzers for Other Therapeutic Areas, 2019-2026
Figure 25: Global Market Shares of IVD Analyzers, by End User, 2020
Figure 26: Global Market for IVD Analyzers, by End User, 2019-2026
Figure 27: Global Market for IVD Analyzers Used in the Diagnostics Laboratories, 2019-2026
Figure 28: Global Market for IVD Analyzers in the Hospitals and Clinics Segment, 2019-2026
Figure 29: Global Market for IVD Analyzers in Research Institutions Segment, 2019-2026
Figure 30: Global Market for IVD Analyzers in Others Segment, 2019-2026
Figure 31: Global Market Shares of IVD Analyzers, by Region, 2020
Figure 32: North American Market Shares of IVD Analyzers, by Country, 2020
Figure 33: U.S. Market for IVD Analyzers, 2019-2026
Figure 34: Canadian Market for IVD Analyzers, 2019-2026
Figure 35: Mexican Market for IVD Analyzers, 2019-2026
Figure 36: European Market Shares of IVD Analyzers, by Country, 2020
Figure 37: German Market for IVD Analyzers, 2019-2026
Figure 38: U.K. Market for IVD Analyzers, 2019-2026
Figure 39: France Market for IVD Analyzers, 2019-2026
Figure 40: Rest of European Market for IVD Analyzers, 2019-2026
Figure 41: Asia-Pacific Market Shares of IVD Analyzers, by Country, 2020
Figure 42: Chinese Market for IVD Analyzers, 2019-2026
Figure 43: Australian Market for IVD Analyzers, 2019-2026
Figure 44: Japanese Market for IVD Analyzers, 2019-2026
Figure 45: Rest of Asia-Pacific Market for IVD Analyzers, 2019-2026
Figure 46: Rest of the World Market for IVD Analyzers, 2019-2026
Figure 47: Global Company Market Shares of IVD Analyzers, 2020
Figure 48: Abbott Laboratories: Annual Revenue, 2018-2020
Figure 49: Abbott Laboratories: Market Shares, by Business Segment, 2020
Figure 50: Abbott Laboratories: Market Shares of Diagnostics Segment, by Region, 2020
Figure 51: Abbott Laboratories: Market Shares of Diagnostics Segment, 2020
Figure 52: Becton, Dickinson and Company: Annual Revenue, 2019 and 2020
Figure 53: Becton, Dickinson and Company: Market Shares, by Region, 2020
Figure 54: Becton, Dickinson and Company: Market Shares, by Business Segments, 2020
Figure 55: bioMerieux SA: Annual Revenue, 2018-2020
Figure 56: bioMerieux SA: Market Shares, by Business Segment, 2020
Figure 57: BioMerieux SA: Market Shares, by Region, 2020
Figure 58: Bio-Rad Laboratories Inc.: Annual Revenue, 2018-2020
Figure 59: Bio-Rad Laboratories Inc.: Market Shares, by Business Segment, 2020
Figure 60: Bio-Rad Laboratories Inc.: Revenue Division, by Region, 2020
Figure 61: Danaher: Annual Revenue, 2018-2020
Figure 62: Danaher: Market Shares, Diagnostic Segment, by Region, 2020
Figure 63: Danaher: Market Shares of Business Segments, 2020
Figure 64: EKF Diagnostics Holdings PLC: Annual Revenue, 2019 and 2020
Figure 65: EKF Diagnostics Holdings PLC: Market Shares, by Region, 2020
Figure 66: EKF Diagnostics Holdings PLC: Market Shares, by Business Segment, 2020
Figure 67: Quidel Corp.: Annual Revenue, 2018-2020
Figure 68: Quidel Corp.: Market Shares, by Region, 2020
Figure 69: Quidel Corp.: Market Shares, by Business Segment, 2020
Figure 70: Roche Diagnostics Corp.: Annual Revenue, 2019 and 2020
Figure 71: Roche Diagnostics Corp.: Market Shares, by Region, 2020
Figure 72: Roche Diagnostics Corp.: Market Shares of Business Segments, 2020
Figure 73: Siemens Healthineers AG: Annual Revenue, 2020 and 2021
Figure 74: Siemens Healthineers AG: Market Shares, by Business Segment, 2021
Figure 75: Siemens Healthineers AG: Market Shares, by Region, 2021
Figure 76: Sysmex: Annual Revenue, 2019 and 2020
Figure 77: Sysmex: Market Shares, by Region, 2020
Figure 78: Sysmex: Revenue Division, by Business Segment, 2020
Figure 79: Thermo Fisher Scientific Inc.: Annual Revenue, 2018-2020
Figure 80: Thermo Fisher Scientific Inc.: Market Shares, by Region, 2020
Figure 81: Thermo Fisher Scientific Inc.: Market Shares, by Business Segment, 2021
Figure 82: Thermo Fisher Scientific Inc.: Market Shares, by Product, 2020

Executive Summary

Reasons for Doing This Study:

In vitro diagnostic tests performed on biological samples (blood, urine, saliva, spinal fluid and DNA) diagnose various diseases or assess health conditions. The information provided by IVD tests enable decision making for health care providers.

Due to recent rapid technological advancements and automation, the range and complexity of diagnostic tests have increased significantly. Disease detection is now possible before the appearance of symptoms, predicting beneficial and adverse treatment outcomes. The growing focus on point-of-care (POC) diagnostics leads to the development of compact and portable analyzers. As more IVD tests become compatible with POC environments, healthcare providers may take advantage of evolving IVDs to effectively treat life-threatening illness, optimizing healthcare delivery.

This report will provide a detailed analysis of key factors governing the growth of the IVD analyzers industry, providing strategic insights and recommendations for those looking to expand.

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Biomerieux Sa
  • Danaher
  • Ekf Diagnostics Holdings plc
  • Mindray Medical International Ltd.
  • Quidel Corp.
  • Roche Diagnostics Corp.
  • Siemens Healthineers AG
  • Sysmex
  • Thermo Fisher Scientific Inc.